| 000 | 01394 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517080215.0 | ||
| 264 | 0 | _c20160718 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0148222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonventre, Josephine A | |
| 245 | 0 | 0 |
_aTargeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics. _h[electronic resource] |
| 260 |
_bPloS one _c2016 |
||
| 300 |
_ae0148222 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeisseria gonorrhoeae _xdrug effects |
| 650 | 0 | 4 |
_aSolvents _xpharmacology |
| 700 | 1 | _aZielke, Ryszard A | |
| 700 | 1 | _aKorotkov, Konstantin V | |
| 700 | 1 | _aSikora, Aleksandra E | |
| 773 | 0 |
_tPloS one _gvol. 11 _gno. 2 _gp. e0148222 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0148222 _zAvailable from publisher's website |
| 999 |
_c25706162 _d25706162 |
||